LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Heparin Sodium Injection (5,000 USP units per mL) in the company’s Simplist™ ready ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals (“Meitheal”), a fully integrated generic injectables company today announced the launch of the Company’s eight presentations of heparin sodium ...
- Nine Heparin Vials to be Differentiated with PreventIV Measures(TM) Packaging and Labeling Features - Download image SCHAUMBURG, Ill., July 1 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a ...
Tarrytown, NY - Early phase III results from the PROTECT trial looking at an oral heparin formulation for the prevention of deep vein thrombosis (DVT) in total hip replacement surgery patients show ...
THE chief obstacles to the wide-scale use of heparin in the treatment of venous thromboembolic disease, are two: the expense of the available commercial heparin preparations and the transiency of ...
Government regulators told doctors Monday to switch from using a blood thinner made by Baxter International, following hundreds of reports of allergic reactions. The Food and Drug Administration said ...
Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, found that ...
The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related ...
Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial ...
Heparin labels updated to clarify drug strength Heparin label changes eliminate the need for clinicians to calculate the total amount of heparin medication in a product containing more than 1 mL.
Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial ...
Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results